Takeda's Oncology Discovery Strategy.

Jpn J Clin Oncol

Millennium Pharmaceuticals, Inc., Cambridge, MA, USA.

Published: April 2013

Takeda's Oncology Discovery Strategy is tightly integrated and focused on first and fast-best-in-class products and product combinations. Core areas of expertise include hormones, protein homeostasis, biotherapeutics and signal transduction. Strategic imperatives for research success are understanding of unmet needs, focus on biological expertise in foundational areas of leadership and flexibility to adapt to new information.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyt023DOI Listing

Publication Analysis

Top Keywords

takeda's oncology
8
oncology discovery
8
discovery strategy
8
strategy takeda's
4
strategy tightly
4
tightly integrated
4
integrated focused
4
focused fast-best-in-class
4
fast-best-in-class products
4
products product
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!